192 related articles for article (PubMed ID: 27354939)
21. Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan.
; Auzanneau C; Bacq D; Bellera C; Blons H; Boland A; Boucheix M; Bourdon A; Chollet E; Chomienne C; Deleuze JF; Delmas C; Dinart D; Espérou H; Geillon F; Geneste D; Italiano A; Jean D; Khalifa E; Laizet Y; Laurent-Puig P; Lethimonnier F; Lévy-Marchal C; Lucchesi C; Malle C; Mancini P; Mathoulin-Pélissier S; Meyer V; Marie-Ange P; Perkins G; Sellan-Albert S; Soubeyran I; Wallet C
ESMO Open; 2020 Jul; 5(4):. PubMed ID: 32713836
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics and Computational Tools for Next-Generation Sequencing Analysis in Clinical Genetics.
Pereira R; Oliveira J; Sousa M
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31947757
[TBL] [Abstract][Full Text] [Related]
23. [Genomic newborn screening. Perspective from the Ethics commission of the Spanish Society for Human Genetics. Part I. Next generation sequencing technologies applied to newborn screening. Challenges and opportunities.].
Pàmpols Ros T; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Blanco Guillermo I
Rev Esp Salud Publica; 2022 Feb; 96():. PubMed ID: 35115483
[TBL] [Abstract][Full Text] [Related]
24. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
[TBL] [Abstract][Full Text] [Related]
25. An integrated approach for analyzing clinical genomic variant data from next-generation sequencing.
Crowgey EL; Stabley DL; Chen C; Huang H; Robbins KM; Polson SW; Sol-Church K; Wu CH
J Biomol Tech; 2015 Apr; 26(1):19-28. PubMed ID: 25649353
[TBL] [Abstract][Full Text] [Related]
26. Clinical validation of targeted next-generation sequencing for inherited disorders.
Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
[TBL] [Abstract][Full Text] [Related]
27. Practical, ethical and regulatory considerations for the evolving medical and research genomics landscape.
Lyon GJ; Segal JP
Appl Transl Genom; 2013 Dec; 2():34-40. PubMed ID: 27942444
[TBL] [Abstract][Full Text] [Related]
28. Validation and Utilization of a Clinical Next-Generation Sequencing Panel for Selected Cardiovascular Disorders.
Celestino-Soper PB; Gao H; Lynnes TC; Lin H; Liu Y; Spoonamore KG; Chen PS; Vatta M
Front Cardiovasc Med; 2017; 4():11. PubMed ID: 28361054
[TBL] [Abstract][Full Text] [Related]
29. Journal of Translational Medicine advances in Translational Genomics and Genetics Era.
Liu W
J Transl Med; 2019 Apr; 17(1):134. PubMed ID: 31023327
[TBL] [Abstract][Full Text] [Related]
30. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
Allegretti M; Fabi A; Buglioni S; Martayan A; Conti L; Pescarmona E; Ciliberto G; Giacomini P
J Exp Clin Cancer Res; 2018 Mar; 37(1):47. PubMed ID: 29506529
[TBL] [Abstract][Full Text] [Related]
31. Managing the genomic revolution in cancer diagnostics.
Nguyen D; Gocke CD
Virchows Arch; 2017 Aug; 471(2):175-194. PubMed ID: 28639053
[TBL] [Abstract][Full Text] [Related]
32. Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms.
Burghel GJ; Hurst CD; Watson CM; Chambers PA; Dickinson H; Roberts P; Knowles MA
Biomed Res Int; 2015; 2015():478017. PubMed ID: 26351634
[TBL] [Abstract][Full Text] [Related]
33. Implementing genomic medicine in pathology.
Williams ES; Hegde M
Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
[TBL] [Abstract][Full Text] [Related]
34. Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
Van Valckenborgh E; Hébrant A; Antoniou A; Van Hoof W; Van Bussel J; Pauwels P; Salgado R; Van Doren W; Waeytens A; Van den Bulcke M
Arch Public Health; 2018; 76():49. PubMed ID: 30202522
[TBL] [Abstract][Full Text] [Related]
35. Access, autonomy, and affordability: ethical and human rights issues surrounding multigene panel testing for cancer in Japan and Switzerland.
Nakasato K; Manz C; Kato K
Front Genet; 2024; 15():1343720. PubMed ID: 38343692
[No Abstract] [Full Text] [Related]
36. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
[TBL] [Abstract][Full Text] [Related]
37. Clinical application of next-generation sequencing for Mendelian diseases.
Jamuar SS; Tan EC
Hum Genomics; 2015 Jun; 9(1):10. PubMed ID: 26076878
[TBL] [Abstract][Full Text] [Related]
38. Managing the ethical challenges of next-generation sequencing in genomic medicine.
Clarke AJ
Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
[TBL] [Abstract][Full Text] [Related]
39. Genomic sequencing in clinical practice: applications, challenges, and opportunities.
Krier JB; Kalia SS; Green RC
Dialogues Clin Neurosci; 2016 Sep; 18(3):299-312. PubMed ID: 27757064
[TBL] [Abstract][Full Text] [Related]
40. Whole-exome/genome sequencing and genomics.
Grody WW; Thompson BH; Hudgins L
Pediatrics; 2013 Dec; 132(Suppl 3):S211-5. PubMed ID: 24298129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
